Exscientia (EXAI)
(Real Time Quote from BATS)
$5.62 USD
-0.04 (-0.71%)
Updated Aug 30, 2024 11:54 AM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Exscientia PLC Sponsored ADR (EXAI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$6.67 | $8.00 | $5.00 | 17.84% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Exscientia PLC Sponsored ADR comes to $6.67. The forecasts range from a low of $5.00 to a high of $8.00. The average price target represents an increase of 17.84% from the last closing price of $5.66.
Analyst Price Targets (3 )
Broker Rating
Exscientia PLC Sponsored ADR currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on four recommendations.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/EXAI.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 2 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 3.00 | 3.00 | 2.00 | 2.33 | 2.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/13/2024 | Not Identified | Not Identified | Strong Buy | Hold |
8/9/2024 | Cowen & Co. | Brendan Smith | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.00 |
ABR (Last week) | 3.00 |
# of Recs in ABR | 4 |
Average Target Price | $6.67 |
LT Growth Rate | 13.50% |
Industry | Medical - Drugs |
Industry Rank by ABR | 93 of 253 |
Current Quarter EPS Est: | -0.31 |